The frequency of OVA257–264-specific CD8+ T cells in the blood was tracked in independent experiments where animals were vaccinated with LM-OVA and later challenged with B16-OVA tumor cells on day 21 (Fig. 2A) day 93 (Fig. 2B) or day 126 (Fig. 2C). The gene discussed is CD8A; the disease is neoplasm.